Estes Ronald E.

Director Estes Ronald E. purchases 800 TRIN shares at $14.16; 3 buys in 7 days as stock down 14.5% from highs

Estes Ronald E. acquired 800 shares at $14.16 on 2026-03-16, his third purchase in seven days (prior buys on 2026-03-11 and 2026-03-03), as Trinity Capital traded at $14.59 currently—down 14.5% from its 52-week high of $17.06. His same-ticker history at TRIN shows mixed outcomes: two prior measurable buys (2025-12-15 and 2025-12-12) achieved 30-day returns of +6.8% and +4.4% respectively, but delivered 90-day returns of -4.4% and -3.0%, with neither proving well-timed at the 90-day mark. A cluster pattern is present: two other insiders also bought within the past 14 days, suggesting broader insider activity during this price decline. The fundamental backdrop is favorable: the company reports net income of $27,645,000.00 and trades at a P/E of 7.48 on a market cap of $1,213,521,980.67.

Director Estes Ronald E. bought 605 shares across 2 transactions (blended avg $14.76) at Trinity Capital (TRIN); holds 39.6K shares post-transaction.

Estes Ronald E., Director of Trinity Capital, made 2 separate purchases totaling 605 shares for $8,929.00, executed at $14.80 and $14.75 on consecutive trading days (2026-03-09 and 2026-03-11). His prior trades at TRIN show a consistent pattern: 5 prior open-market buys at this ticker, with measurable 90-day returns of +6.6%, +6.6%, +4.5%, +4.4%, and +6.8% respectively—all positive outcomes. The stock is currently trading at $14.80, down 13.2% from its 52-week high of $17.06 and down 8.4% over 30 days, suggesting these purchases occurred during a near-term drawdown. A cluster of 2 other insiders also bought within the past 14 days, aligning with director buying activity. The company carries a low P/E of 7.59 on net income of $27,645,000.00.

Director Estes purchases 200 shares of TRIN at $14.73; latest in a series of 5 buys at same ticker with 3 of 3 measurable 90-day outcomes positive.

Estes Ronald E., a Director at Trinity Capital Inc., purchased 200 shares at $14.73 on 2026-03-03, bringing his total holdings to 39,038 shares. This purchase continues an established pattern: he has executed 5 prior buys at TRIN over the preceding months, and across these same-ticker trades, 3 of 3 prior buys with measurable 90-day outcomes each delivered positive returns (+6.6%, +6.6%, and +10.7%). His cross-ticker track record across 20 prior open-market buys shows an average 90-day return of +4.8% with a 72.22% win rate. The current stock price of $15.11 sits -11.4% from its 52-week high of $17.06 and has declined -7.6% over the past 30 days, while the company trades at a P/E of 7.75 with a market cap of $1,256,772,935.43. The repetition of his buys at this ticker, combined with his historical accuracy in timing those purchases, presents a data point worth monitoring as the stock navigates recent downward pressure.

Director Estes Ronald E. bought 1,500 shares at blended average $15.10 (Dec 12–15), raising stake to 38,443 shares; stock at $14.98 vs 52-week high $16.56.

Ronald E. Estes executed two separate open-market purchases totaling 1,500 shares for $22,655.00, raising his holdings by 4.1% from 36,943 to 38,443 shares. His trades occurred at $15.15 and $15.08—only $0.17 above the current price of $14.98, placing them near recent support but 9.5% below the 52-week high of $16.56. His cross-ticker track record shows a modest 70.59% 90-day win rate with an average 90-day return of +3.9%, but at Trinity Capital specifically, his five prior purchases have yielded mixed outcomes: two measurable prior buys posted -10.2% and -10.0% 30-day returns, with a 90-day win rate of 0%. Trinity's fundamentals are solid—P/E of 7.97 and a profitable $27.6M net income—but the stock has declined 6.9% over 90 days, placing this purchase in a downward environment and offering no clear evidence of prescient timing at this ticker.

Director Ronald E. Estes buys 1,500 shares of TRIN at blended $14.44 avg, adding 4.2% to holdings; stock down 13.8% from 52-week high.

Director Ronald E. Estes executed 2 separate purchases totaling 1,500 shares for $21,655.00 over two consecutive trading days (November 18-19, 2025) at prices averaging $14.44, increasing his holdings from 35.4K to 36.9K shares. The purchases occur at a point where TRIN trades 13.8% below its 52-week high of $16.56 and down 3.9% over the prior 30 days. His cross-ticker track record shows 18 prior buys with a 100.00% 90-day win rate and average 90-day return of +8.2%, though his 5 prior trades at TRIN show consistent 30-day losses ranging from -10.0% to -10.5%, with no yet-measurable 90-day outcomes at this ticker. A cluster pattern is present: 2 other insiders also bought within the past 14 days. The company trades at a P/E of 7.60 with net income of $27.6M and market cap of $1.1B, suggesting a low valuation multiple.

Director Estes Ronald E. buys 2,000 shares of TRIN at $14.44; now holds 38,778 shares. Cluster buy pattern with 2 others in 14 days.

Director Estes Ronald E. purchased 2,000 shares at $14.44, increasing his holdings to 38,778 shares—a 5.4% addition to his prior position. This purchase is part of a cluster pattern with 2 other insiders buying within the same 14-day window, suggesting coordinated director-level confidence. However, the insider's recent TRIN-specific purchase history shows five consecutive buys (Sept 3–12, 2025) all underwater in the 30-day window (ranging -5.6% to -10.5%), indicating these recent purchases have not yet recovered. At a P/E of 7.83 and market cap of $1.1B, the company carries a conservative valuation, but near-term price momentum (30-day: +1.9%, 90-day: -7.2%) has been mixed. The cluster activity suggests insider belief, though recent timing at this ticker has not yet produced gains.

Director Estes Ronald E. purchased 1,000 shares of Trinity Capital (TRIN) at $16.08 on 2025-09-12; now holds 36,778 shares post-transaction.

Estes Ronald E., a director, made an open-market purchase of 1,000 shares at $16.08, adding to his holdings of 36.8K shares (a +2.8% increase). This transaction occurred within a context of recent repeated buying activity at TRIN: four prior purchases at this ticker occurred between 2025-09-03 and 2025-09-11, demonstrating a pattern of accumulation in the days immediately before and after this trade. At the cross-ticker level, Estes's historical track record shows 16 prior buys with a 100.00% 90-day win rate and +8.2% average 90-day return, though his TRIN-specific prior trades (from 2025-06-12 onward) have not yet accumulated measurable 30- or 90-day returns for most transactions. The stock currently trades at $16.02, only 0.37% below the transaction price, and stands +11.8% over the trailing 90 days and -3.3% from its 52-week high of $16.56. With a P/E of 8.13 and net income of $41.4M supporting a market cap of $1.1B, the company's valuation metrics remain within a narrow range. The pattern of consecutive buying activity warrants attention to whether there is a material catalyst or information flow driving these discretionary purchases.

Director Estes Ronald E. purchases 3,000 shares across 3 transactions for $48,290.00 at TRIN; holdings rise to 35,778 shares.

Estes Ronald E., a Director, executed three separate open-market purchases totaling 3,000 shares (3.0K shares) at prices ranging from $16.05 to $16.14 on 2025-09-10 and 2025-09-11. His holdings increased by 9.2% to 35,778 shares (35.8K shares). The timing is notable: at the 90-day mark, his five prior purchases at Trinity Capital show a 100% win rate with returns of +11.3%, +11.0%, and +12.8%, suggesting consistent ability to enter at opportune moments. The current price of $16.11 is -2.7% from the 52-week high of $16.56, positioning these recent purchases slightly above mid-range valuations. With a P/E of 8.18 on net income of $41,414,000.00 in a $1.1B market cap company, the insider activity occurs in a fundamentally modest valuation environment.

Director Estes Ronald E. buys 1,000 shares of TRIN at $16.15; stock up 7.1% in 30 days, 11.4% in 90 days; P/E 8.22.

Director Estes Ronald E. purchased 1,000 shares at $16.15 on 2025-09-03, increasing his holdings from 31,778 to 32,778 shares. The purchase occurs as Trinity Capital trades at $16.19 (current), within the 52-week range of $13.11–$16.56, and follows a recent 30-day gain of 7.1% and 90-day gain of 11.4%. His prior trades at TRIN show mixed near-term results: three prior buys in June 2025 posted negative 30-day returns of -0.5%, -1.3%, and -0.4%, though two older buys from November 2024 showed positive 30-day returns of +7.5% and +7.9%. At the 90-day measurement window, the stock has risen for 3 of his 3 prior TRIN trades where outcomes are measurable. The company's fundamentals show a P/E of 8.22 and market cap of $1,138,386,250.40, with net income of $41,414,000.00. This transaction adds to a director-level position that is now material relative to market opportunity.

Director Ronald E. Estes purchases 1,700 shares at $14.53 avg; prior 4 TRIN buys all delivered 10.3%–11.6% 90-day gains

Ronald E. Estes, Director of Trinity Capital Inc., made 2 separate purchases totaling 1,700 shares for $24,700.00 on 2025-06-11 and 2025-06-12, increasing his holdings by 5.7% to 31,778 shares. His purchase prices of $14.60 and $14.48 bracket the current price of $14.45, placing the transaction near current levels. Critically, his prior 4 open-market buys at TRIN (all on 2024-11-01) delivered consistent 90-day returns of 10.3%, 10.6%, 10.7%, and 11.6%, with a 100% well-timed rate at this ticker; across all tickers, his cross-ticker track record shows 10 prior buys with a 90d win rate of 100.00%. The company's P/E of 7.30 and market cap of $934.2M provide a backdrop of moderate valuation, though the stock is -12.7% from its 52-week high and down 8.7% over 90 days. This filing warrants attention as Estes' demonstrated accuracy in prior TRIN timing combined with his reinvestment signal suggests informed conviction at current levels.